Abstract

We aim to investigate the prognostic significance of HER2/CEP17 ratio, HER2 copy numbers, and tumor infiltrating lymphocytes (TILs) among early HER2+ breast cancer patients treated with HER2-targeted therapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P1-02-03: Tumor-infiltrating lymphocytes but not HER2 copy number or ratio show prognostic value in trastuzumab-treated HER2-positive breast cancer
Stephanie Robertson ... Caroline Rönnlund
American Journal of Cancer | VOL. 82
Stephanie Robertson, et. al.Stephanie Robertson ... Caroline Rönnlund
15 Feb 2022
Abstract P3-09-05: Genomic and clinical characterization of breast tumors with unusual HER2 FISH pattern (ratio < 2, HER2 copy number ≥ 6): Are they mostly HER2 “positive?”
Christina H Wei ... Lixin Yang
American Journal of Cancer | VOL. 82
Christina H Wei, et. al.Christina H Wei ... Lixin Yang
15 Feb 2022
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies.
Jing Zhao ... Jane Meisel
Breast cancer research and treatment | VOL. 183
Jing Zhao, et. al.Jing Zhao ... Jane Meisel
26 Jul 2020
HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer.
Yi‐Fang Tsai ... Yu‐Ling Wang
Histopathology | VOL. 74
Yi‐Fang Tsai, et. al.Yi‐Fang Tsai ... Yu‐Ling Wang
29 Jan 2019
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers